Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus

Neuropsychopharmacology

Volumn 21, Issue 3, 1999, Pages 352-367

  Mullins, U Lena ^a   Gianutsos, G ^b   Eison, A S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

5 HT7; Antidepressants; Circadian rhythm; SCN; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYLTRYPTAMINE; ANTIDEPRESSANT AGENT; CLORGYLINE; DESIPRAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NOMIFENSINE; PHENELZINE; RACLOPRIDE; SEROTONIN 7 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0032806873     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00041-X     Document Type: Article

References (100)

1. 2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychchiat. 47:1990;1038-1047.
2. Armstrong S., Redman J. Melatonin and circadian rhythmicity. Reiter Yu Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications:1993;187-224 CRC Press, New York.
3. 2 binding sites in the frontal cortex of suicide victims and control subjects Amer J Psychiat. 146:1989;730-746.
4. 7) positively coupled to adenylate cyclase. J Biol Chem. 268:1993;23422-23426.
5. Baldessarini R. Drugs and treatment of psychological disorders. Goodman Gilman The Pharmacological Basis of Therapeutics. 8th ed:1990;389-435 Pergamon Press, New York.
6. Beck C., Fibiger H.C. Chronic desipramine alters stress-induced behaviors and regional expression of the immediate early gene, c-Fos. Pharm Biochem Behav. 51:1995;331-338.
7. 2 receptor binding on blood platelets as a state- dependent marker in major affective disorder. Psychopharmacology. 102:1990;73-75. a.
8. 2 receptor binding on blood platelets of suicidal men. Psychopharmacology. 100:1990;165-167. b.
9. Binkley S. Structures and molecules involved in the generation and regulation of biological rhythms in vertebrates and invertebrates. Experientia. 49:1993;648-653.
10. Brown G., Seggie J. Effects of antidepressants on entrainment of circadian rhythms. Prog. Neuro-Psychopharmacol Biol Psychiat. 12:1988;299-306.
11. Carlsson A., Svennerholm L., Winblad B. Seasonal and circadian monoamine variations in human brains examined postmortem. Acta Psycht Scand. 61:1980;5-85.
12. Cassone V., Warren W., Brooks D., Lu J. Melatonin, the pineal gland, and circadian rhythms. J Biol Rhythms. 8:1993;S73-S81.
13. Chen J., Kelz M., Hope B., Nakabeppa Y., Nestler E. Chronic Fos-related antigens. Stable variants of delta FosB induced in brain by chronic treatments J Neurosci. 17:1997;4933-4941.
14. Coiro V., Volpi R., Marchesi C., DeFerri A., Davoli C., Caffarra P., Rossi G., Caffarri G., Davolio M., Chiodera P. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Psychoneuroendocrinology. 18:1993;551-556.
15. Cooper J.R., Bloom F.E., Roth R.H. Serotonin. In The Biochemical Basis of Neuropharmacology. 7th ed:1996;352-391 Oxford University Press, New York.
16. 1A receptor agonist 8-OH-DPAT and other nonphotic stimuli on the circadian rhythm of wheel-running activity in hamsters under different constant conditions. Neurosci Lett. 172:1994;27-30.
17. Dawson D., Armstrong S.M. Chronobiotics - Drugs that shift rhythms. Pharmacol Ther. 69:1996;15-36.
18. Delgado P., Price L., Heninger G., Charney D. Neurochemistry. Paykel Handbook of Affective Disorders. 1992;219-253 Guilford Press, New York.
19. DeMet E., Chicz-DeMet A. Effects of psychoactive drugs on circadian rhythms. Psychiat Ann. 17:1987;682-688.
20. Dragunow M., Faull R. The use of c-Fos as a metabolic marker in neuronal pathway tracing. J Neurosci Meth. 29:1989;261-265.
21. Dubocovich M.L. Melatonin receptors in the central nervous system. Adv Exp Med Biol. 36:1991;255-265.
22. Duman R.S., Nibuya M., Nestler E.J. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;1-7.
23. Duncan W. Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther. 71:1996;253-312.
24. Edgar D.M., Miller J.D., Prosser R.A., Dean R.R., Dement W.C. Serotonin and the mammalian circadian system II. Phase-shifting rat behavioral rhythms with serotonergic agonists. J Biol Rhythms. 8:1993;17-31.
25. Edgar D.M., Seidel W.F., Dement W.C. Effects of buspirone on sleep-wake cycle and body temperature circadian rhythms in the rat. Sleep Res. 19:1994;58-59.
26. File S.E. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis. Pharmacol Ther. 46:1990;357-375.
27. Ginty D., Kornhauser J., Thompson M., Bading H., Mayo K., Takahashi J., Greenberg M. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science. 260:1993;238-241.
28. 1A receptor agonists. Brain Res. 638:1994;235-242.
29. Golda V. The relationship between circadian rhythm of motor activity and circadian rhythm of core body temperature. Homeostasis. 34:1993;108-111.
30. Goodwin F.K., Wirz-Justice A., Wehr T.A. Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. Costa Ragni Typical and Atypical Antidepressants. Clinical Practice:1982;1-11 Raven Press, New York.
31. 7 receptor in rat brain. Br J Pharmacol. 117:1996;657-666.
32. Hallonquist J.D., Golberg M.A., Brandes J.S. Affective disorders and circadian rhythms. Can J Psychiat. 31:1986;259-272.
33. 1A receptors. Pharmacological, biochemical, functional, and regulatory properties Ann NY Acad Sci. 600:1990;114-131.
34. Healy D. Rhythm and blues. Neurochemical, neuropharmacological, and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders. Psychopharmacology. 93:1987;271-285.
35. Hoffman G.E., Smith S., Verbalis J. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol. 14:1993;173-213.
36. Hope B., Nye H., Kelz M., Self D., Iadarola M., Duman R., Nestler E. Induction of long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron. 13:1994;1235-1244.
37. Hyman S., Nestler E. Initiation and adaptation. A paradigm for understanding psychotropic drug action Am J Psychiat. 153:1996;151-162.
38. Ibata I., Tanaka M., Tamada Y., Okamura H. The suprachiasmatic nucleus. A circadian oscillator Neuorscientist. 3:1997;215-225.
39. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev. 72:1992;165-229.
40. Kennaway D, Moyer R, Turker K (1996): Quipazine mimics the effects of a light pulse on melatonin rhythmicity and induces suprachiasmatic Fos expression in the rat. Abstract #551.13, Proceedings of the Society For Neuroscience 26th Annual Meeting Program, 22:1333.
41. Kilduff K.S., Landel H.B., Nagy G.S., Sutin E.L., Dement W.C., Heller H.C. Melatonin influences Fos expression in the rat suprachaismatic. Mol Brain Res. 16:1992;47-56.
42. Kornhauser J.M., Mayo K., Takahashi J.S. Immediate early gene expression in a mammalian circadian pacemaker. The suprachiasmatic nucleus Young Dekker Molecular Genetics of Biological Rhythms. 1992;271-306 Massachusetts, Sinauer Associates, Sunderland.
43. Kupfer D.J. Sleep research in depressive illness. Clinical implications Biol Psychiat. 38:1995;391-403.
44. Kupferman I. The limbic system. Kandel D.B., Schwartz R.C., Jessell T. Principles of Neural Science. 3rd ed:1991;826-831 Connecticut, A, Norwalk. leton and Lange
45. Lemke G. Gene regulation in the nervous system. Hall An Introduction to Molecular Neurobiology. 1st ed:1992;313-331 Massachusetts, Sinaur Associates, Sunderland.
46. 7) implicated in the regulation of mammalian circadian rhythms. Neuron. 11:1993;449-458.
47. Medanic M., Gillette M.U. Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro only during the subjective day. J Physiol. 450:1992;620-642.
48. Meijer J.H., Groos G.A. Responsiveness of suprachiasmatic and ventral lateral geniculate neurons to serotonin and imipramine. A microiontophoretic study in normal and imipramine-treated rats Brain Res Bull. 20:1988;89-96.
49. Meyer-Bornstein E., Morin L.P. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J Neurosci. 16:1996;2097-2111.
50. Miller J., Morin L., Schwartz W., Moore R. New insights into the mammalian circadian clock. Sleep. 19:1996;641-667.
51. Moore R (1995): Organization of the mammalian circadian system. In Circadian Clocks and Their Adjustment. Proceedings of Ciba Foundation Symposium. New York, J. Wiley & Sons, pp 88-116.
52. Morgan J., Curran T. Stimulus-transcription coupling in neurons. Role of cellular immediate-early genes Trends Neurosci. 12:1989;459-462.
53. Morgan J., Curran T. Proto-oncogenes in the CNS. Bloom Kupfer Psychopharmacology. The Fourth Generation of Progress:1995;631-642 Raven Press, New York.
54. Morin L.P., Blanchard J. Depletion of brain serotonin by 5,7-DHT modifies hamster circadian rhythm response to light. Brain Res. 566:1991;173-185.
55. Morin L.P. The circadian visual system. Brain Res Rev. 67:1994;102-127.
56. Mullins UL, Gianutsos GG, Eison AS (1999) Characterization of melatonin-mediated Fos-like immunoreactivity in the ventrolateral suprachiasmatic nucleus of the rat. J Rec Sig Trans Res 19:781-801.
57. 1A receptors to 8-OH-DPAT in rats. Psychopharmacology. 123:1996;42-45.
58. Nair N.P., Sharma M. Neurochemical and receptor theories of depression. Psychiat J Univ Ottawa. 14:1989;328-341.
59. Oren D., Rosenthal N. Seasonal affective disorders. Paykel Handbook of Affective Disorders. 1992;551-567 Guilford Press, New York.
60. Pandey G., Pandey S., Janicak P., Marks R., Davis J. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psych. 28:1990;215-222.
61. Partonen T. The molecular basis of winter depression. Annals Med. 26:1994;239-243.
62. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
63. Pennypacker K., Hong S., McMillan M. Implications of prolonged expression of Fos-related antigens. Trends Pharm Sci. 16:1995;317-321.
64. Plassat J., Amalaiky N., Hen R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol Pharmacol. 44:1993;229-236.
65. Prosser R.A., Gillette M.U. The mammalian circadian clock in the suprachiasmatic nucleus is reset in vitro by cAMP. J Neurosci. 9:1989;1073-1081.
66. Prosser R.A., Heller H.C., Miller J.D. A serotonin agonist phase shifts the circadian clock in the suprachiasmatic nucleus in vitro. Brain Res. 534:1990;336-339.
67. Prosser R.A., Dean R.R., Edgar D.M., Heller H.C., Miller J.D. Serotonin and the mammalian circadian system I. In vitro phase shifts by serotonergic agonists and antagonists. J Biol Rhythms. 8:1993;1-16.
68. Ranson S.W. The hypothalamus. Its significance for visceral innervation and emotional expression Trans. Coll. Physicians Phila. 2:1934;222-242.
69. Reiter R. The melatonin rhythm. Both a clock and a calendar Experentia. 49:1993;654-664.
70. Richelson E. Antidepressants and brain neurochemistry. Mayo Clinic Proc. 65:1990;1227-1236.
71. Roca A.L., Weaver D.R., Reppert S.M. Serotonin receptor gene expression in the rat suprachiasmatic nuclei. Brain Res. 608:1993;159-165.
72. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol Exp Ther. 268:1994;1403-1410.
73. 7) activating cAMP formation. Proc Natl Acad Sci. 90:1993;8547-8551.
74. Saxena P.R. Serotonin receptors. Subtypes, functional responses, and therapeutic relevance Pharmac Ther. 66:1995;339-368.
75. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci. 51:1949;660-672.
76. Schwartz W.J. A clinician's primer on the circadian clock. Its localization, function, and resetting Adv Int Med. 38:1993;81-106.
77. Schwaninger M., Weisbod M., Knepel W. Progress in defining the mechanism of action of antidepressants. CNS Drugs. 8:1997;237-243.
78. Selim M., Glass J., Hauser U., Rea M. Serotonergic inhibition of light-induced Fos expression and extracellular glutamate release in the SCN. Brain Res. 621:1993;181-188.
79. 7 serotonin receptor subtype. J Biol Chem. 268:1993;18200-18204.
80. Sheng M., Greenberg M.E. The regulation and function of c-Fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
81. Shibata S., Tsuneyoski A., Hamada T., Tominaga K., Watanabe S. Phase-resetting effect of 8-OH-DPAT, a serotonin-1A agonist, on the circadian rhythm of firing rate in the rat suprachiasmatic nucleus in vitro. Brain Res. 582:1992;353-356.
82. Siever L., Davis K. Overview. Toward a dysregulation hypothesis of depression Am J Psych. 1017-1031:1985.
83. 7 receptor binding sites in rat hypothalamus. Sensitivity to chronic antidepressant treatment Mol Pharm. 47:1995;99-103.
84. Smale L., Michels K.M., Moore R.Y., Morin L.P. Destruction of the hamster serotonergic system by 5,7-DHT. Effects on circadian rhythm phase, entrainment, and response to triazolam Brain Res. 515:1990;9-19.
85. Souetre E., Salvati E., Wehr T., Sack D., Krebs B., Darcourt G. Twenty- hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission. Am J Psych. 145:1988;1133-1137.
86. Stankov B., Fraschini F., Reiter R. The melatonin receptor. Distribution, biochemistry, and pharmacology Reiter and Yu Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications:1993;155-186 CRC Press, New York.
87. Sumner B.E., Rosie R., Fink G. Relative density of 5-hydroxytryptamine receptor subtype mRNAs in female rat neuroendocrine brain determined by in situ hybridization histochemistry. Mol Cell Neurosci. 3:1992;215-223.
88. Sutin E.L., Kilduff T.S. Circadian and light-induced expression of immediate early gene mRNAs in the rat suprachiasmatic nucleus. Mol Brain Res. 15:1992;281-290.
89. 7 receptors in guinea-pig brain. Br J Pharmacol. 115:1995;107-116.
90. 7 receptor positively coupled to adenylyl cyclase. J Neurochem. 63:1994;456-464.
91. Van De Kar L.D., Lorens S.A. Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei. Brain Res. 162:1979;45-54.
92. Van Den Pol A.N., Dudek F.E. Cellular communication in the circadian clock, the suprachiasmatic nucleus. Neurosci. 56:1993;793-811.
93. Waeber C., Moskowitz M.A. Autoradiographic visualization of [3H]5-carboxamidotryptamine binding sites in the guinea-pig and rat brain. Eur J Pharmacol. 283:1995;31-46.
94. Wehr T., Wirz-Justice A., Goodwin F., Duncan W., Gillin J. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science. 206:1979;710-713.
95. Wirz-Justice A., Campbell I.C. Antidepressant drugs can slow or dissociate circadian rhythms. Experentia. 38:1982;1301-1309.
96. Wirz-Justice A., Krauchi K., Brunner D.P., Graw P., Haug H., Leonhardt G., Sarrafzadeh A., Arendt J. Circadian rhythms and sleep regulation in seasonal affective disorder. Acta Neuropsychiat. 7:1995;41-53.
97. Wollnick F. Effects of chronic administration and withdrawal of antidepressant agents on circadian activity rhythms in rats. Pharmacol Biochem Behav. 43:1992;549-561.
98. Wollnick F., Brysch W., Uhlmann E. Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock. Eur J Neurosci. 7:1995;388-393.
99. Ying S.W., Rusak B. Effects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleus. Brain Res. 651:1994;37-46.
100. Zelman F.P., Garver D.L. Depression and antidepressant therapy. Receptor dynamics Prog Neuropsychopharm Biol Pyschiat. 14:1990;503-523.